The EMA has lifted restrictions on the chikungunya vaccine in people 65 and older, while warning that it should be used only ...

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 ...

Controversial precautionary rules imposed last year for prescribing valproate to potentially fertile males are being assessed ...

Valneva ( ($VALN) ) just unveiled an update. On July 11, 2025, Valneva announced that the European Medicines Agency (EMA) lifted the temporary ...

At its July meeting, the European Medicines Agency’s pharmacovigilance committee (PRAC) completed its review of French ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...

EMA lifts suspension on Valneva's chikungunya vaccine for older adults, emphasizing its importance in high-risk situations.

An experimental drug, Elinzanetant, has shown promise in reducing menopause symptoms in breast cancer patients undergoing ...

The European Commission (EC) has approved Biocon Biologics’ biosimilars referencing Amgen’s bone disease therapy denosumab.

People of a certain age may remember Merthiolate and Mercurochrome in the household medicine chest. Whenever someone skinned a knee or scraped an elbow, one of these topical antiseptics was often ...